Liver transplantation from hepatitis B surface antigen positive donors: A safe way to expand the donor pool

Journal of Hepatology

Volumn 56, Issue 3, 2012, Pages 579-585

  Loggi, Elisabetta ^a   Micco, Lorenzo ^a   Ercolani, Giorgio ^b   Cucchetti, Alessandro ^b   Bihl, Florian K ^c,d   Grazi, Gian Luca ^e   Gitto, Stefano ^a   Bontadini, Andrea ^b   Bernardi, Mauro ^a   Grossi, Paolo ^f,g   Nanni Costa, Alessandro ^g   Pinna, Antonio Daniele ^b   Brander, Christian ^h,i   Andreone, Pietro ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Bellinzona Hospital   (Switzerland)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^e REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^f UNIVERSITY OF INSUBRIA   (Italy)

^g ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^h HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

ⁱ INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

Hepatitis B surface antigen positive donor; Hepatitis B virus (HBV); Immune response; Liver transplantation; Marginal graft

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; ORGAN DONOR; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; AGED; AMINO ACID SEQUENCE; ANTIVIRAL AGENTS; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; T-LYMPHOCYTES; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; TREATMENT OUTCOME;

EID: 84857370232     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.09.016     Document Type: Article

References (21)

1. R.C. Afonso, R. Hidalgo, A.T. Paes, M.P. Zurstrassen, L.E. Fonseca, and F.L. Pandullo Impact of cumulative risk factors for expanded criteria donors on early survival after liver transplantation Transplant Proc 40 2008 800 801
2. R. Montalti, B. Nardo, R. Bertelli, P. Beltempo, L. Puviani, and M. Vivarelli Donor pool expansion in liver transplantation Transplant Proc 36 2004 520 522
3. M.B. Rocha, I.F. Boin, C.A. Escanhoela, and L.S. Leonardi Can the use of marginal liver donors change recipient survival rate? Transplant Proc 36 2004 914 915
4. D. Lavanchy Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures J Viral Hepat 11 2004 97 107
5. E. Cholongitas, G.V. Papatheodoridis, and A.K. Burroughs Liver grafts from anti-hepatitis B core positive donors: a systematic review J Hepatol 52 2010 272 279
6. R.P. Gonzalez-Peralta, J.M. Andres, F.Y. Tung, J.W. Fang, M.E. Brunson, and G.L. Davis Transplantation of a hepatitis B surface antigen-positive donor liver into a hepatitis B virus-negative recipient Transplantation 58 1994 114 116
7. J.K. Ho, P.R. Harrigan, C.H. Sherlock, U.P. Steinbrecher, S.R. Erb, and T. Mo Utilization of a liver allograft from a hepatitis B surface antigen positive donor Transplantation 81 2006 129 131
8. S. Hwang, S.G. Lee, K.M. Park, K.H. Kim, C.S. Ahn, and H.B. Oh Five-year follow-up of a hepatitis B virus-positive recipient of hepatitis B surface antigen-positive living donor liver graft Liver Transpl 12 2006 993 997
9. Y. Soejima, M. Shimada, A. Taketomi, T. Yoshizumi, H. Uchiyama, and T. Ikegami Successful living donor liver transplantation using a graft from a hepatitis B surface antigen-positive donor Liver Int 27 2007 1282 1286
10. A. Franchello, V. Ghisetti, A. Marzano, R. Romagnoli, and M. Salizzoni Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta co-infection Liver Transpl 11 2005 922 928
11. R.P. Perrillo, and J.D. Eason The use of HBsAg-positive organ donors: far more than meets the eye? Liver Transpl 11 2005 875 877
12. Criteri e modalita' per la certificazione dell'idoneita' al trapianto degli organi prelevati al trapianto (art. 14, comma 5, legge 1 aprile 1999, n.91), Decreto 2 agosto 2002. Gazzetta Ufficiale della Repubblica Italiana.
13. E. Loggi, F. Bihl, J.V. Chisholm 3rd, M. Biselli, A. Bontadini, and G. Vitale Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft J Hepatol 50 2009 625 630
14. K. Ishak, A. Baptista, L. Bianchi, F. Callea, J. De Groote, and F. Gudat Histological grading and staging of chronic hepatitis J Hepatol 22 1995 696 699
15. F. Piscaglia, V. Camaggi, M. Ravaioli, G.L. Grazi, M. Zanello, and S. Leoni A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system Liver Transpl 13 2007 857 866
16. L.H. Katz, M. Paul, D.G. Guy, and R. Tur-Kaspa Prevention of recurrent hepatitis B virus infection after liver transplantation: hepatitis B immunoglobulin, antiviral drugs, or both? Systematic review and meta-analysis Transpl Infect Dis 12 2010 292 308
17. F.K. Bihl, E. Loggi, J.V. Chisholm 3rd, H.S. Hewitt, L.M. Henry, and C. Linde Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti-CD3 mAb T-cell expansion, "RecycleSpot" J Transl Med 3 2005 20
18. E.J. Gane The natural history of recurrent hepatitis C and what influences this Liver Transpl 14 2008 S36 S44
19. M.R. Brunetto, F. Oliveri, P. Colombatto, F. Moriconi, P. Ciccorossi, and B. Coco Use of hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers Gastroenterology 139 2010 483 490
20. S. Saab, S. Desai, D. Tsaoi, F. Durazo, S. Han, and A. McClune Posttransplantation hepatitis B prophylaxis with combination oral nucleoside and nucleotide analog therapy Am J Transplant 11 2011 511 517
21. E.J. Wherry, J.N. Blattman, K. Murali-Krishna, R. van der Most, and R. Ahmed Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment J Virol 77 2003 4911 4927